Expand CRVS Menu
CRVS MENU

CRVS Latest Press Releases

-- November 4, 2025 --

Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2025 Financial Results Globe Newswire 4:01 PM

-- November 3, 2025 --

Corvus Pharmaceuticals to Present Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial at the 67th American Society of Hematology Annual Meeting & Exposition Globe Newswire 9:02 AM

-- October 31, 2025 --

Corvus Pharmaceuticals to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference Globe Newswire 7:30 AM

-- October 28, 2025 --

Corvus Pharmaceuticals to Provide Business Update and Third Quarter 2025 Financial Results on November 4, 2025 Globe Newswire 4:01 PM

-- October 21, 2025 --

The Institute for Follicular Lymphoma Innovation (IFLI) Appoints Innovative Leaders Mehrdad Mobasher, M.D., M.P.H., and Carol O'Hear, M.D., Ph.D., as Executive Partners PRNewswire 8:05 AM

-- October 17, 2025 --

Corvus Pharmaceuticals Announces Presentation of Interim Data from the Phase 1b/2 Clinical Trial of Ciforadenant for Patients with Metastatic Renal Cell Cancer at the European Society for Medical Oncology (ESMO) Congress 2025 Globe Newswire 10:00 AM

-- October 2, 2025 --

Corvus Pharmaceuticals Appoints David Moore to Board of Directors Globe Newswire 4:01 PM

-- August 7, 2025 --

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2025 Financial Results Globe Newswire 4:01 PM

-- July 31, 2025 --

Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2025 Financial Results on August 7, 2025 Globe Newswire 4:01 PM
Market Data Delayed 15 Minutes